Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT01017939 A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone Wi… |
Abiraterone acetate | SEP | Phase 1 | COMPLETED | En attente / non publié | Janssen Research & Development, L… | United States, Canada · BC Cancer Agency, Vancouver, … | 2010-01 → 2012-04 | Ouvrir |
| NCT02340520 Enhancement of Corticosteroid Efficacy in COPD |
Theophylline | SEP | Phase 3 | COMPLETED | En attente / non publié | Massachusetts General Hospital | United States · UConnHealth, Farmington, United States | 2014-12 → 2016-08 | Ouvrir |
| NCT02880033 LymphoEnergy — Oxidative Stress and Apoptosis of Energy Metabolism by D… |
deferiprone | Sclérose latérale amyotrophique | Non applicable | COMPLETED | En attente / non publié | University Hospital, Lille | France · Hôpital Roger Salengro, CHRU de Lille, Lille… | 2011-02 → 2020-03 | Ouvrir |
| NCT05744310 ALS-LTMV — Effects of Long Term Ventilation Support on the Quality of L… |
Long term mechanical ventilation … | Sclérose latérale amyotrophique | Non applicable | RECRUITING | En attente / non publié | Haukeland University Hospital | Norway · Akershus University Hospital, Lørenskog, Nor… | 2023-04-21 → 2032-08-21 | Ouvrir |
| NCT06881979 Fit4MR-ChrMND — High-Tech Rehabilitation Pathway for Chronic Adult Neur… |
High-tech rehabilitative treatment | Sclérose latérale amyotrophique | Non applicable | RECRUITING | En attente / non publié | Istituti Clinici Scientifici Maug… | Italy · Azienda Ospedaliero-Universitaria di Modena, … | 2025-04-28 → 2026-11 | Ouvrir |
| NCT07833618 A Phase II Study of ALT001 in Patients With Amyotrophic Lateral Scleros… |
ALT001 1.0 μg/kg | Sclérose latérale amyotrophique | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Darwin Origin (Hubei) Biopharmace… | China · Capital Medical University Affiliated Beijing… | 2026-09-01 → 2028-12-31 | Ouvrir |
| NCT07082192 A Study to Evaluate the Efficacy and Safety of Different Doses of CB03-… |
Test drug CB03-154 5mg group | Sclérose latérale amyotrophique | Phase 2/3 | RECRUITING | En attente / non publié | Shanghai Zhimeng Biopharma, Inc. | China · Peking University Third Hospital, Beijing, Ch… | 2025-10-30 → 2027-10 | Ouvrir |
| NCT07834450 CORTEX-ALS — Efficacy and Safety of Cyclophosphamide in Amyotrophic Lat… |
Cyclophosphamide | Sclérose latérale amyotrophique | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | University of Washington | Non communiqué | 2026-10-01 → 2029-09-30 | Ouvrir |
| NCT07836751 Using Gaze to Enable Head-neck Movements in Patients With Head Drop |
neck exoskeleton controller | Sclérose latérale amyotrophique | Non applicable | RECRUITING | En attente / non publié | University of Utah | United States · Utah Wearable Robotics Laboratory, De… | 2025-06-30 → 2026-12-01 | Ouvrir |
| NCT07838389 Evaluation of Donor-Derived B Cell Infusions in Patients With Amyotroph… |
B cell infusion | Sclérose latérale amyotrophique | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Mark Poznansky | United States · Sean M. Healey and AMG Center for ALS… | 2027-09 → 2030-01 | Ouvrir |
| NCT05407324 DAZALS — Dazucorilant in Patients With Amyotrophic Lateral Sclerosis |
Dazucorilant 300 mg | Sclérose latérale amyotrophique | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Corcept Therapeutics | United States, Belgium, Canada, France, Germany, Irel… | 2022-11-15 → 2027-11 | Ouvrir |
| NCT07465289 MyVisionXT — A Study to Evaluate The Long-Term Safety And Efficacy of R… |
rozanolixizumab | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | UCB Biopharma SRL | United States, China, Japan, Spain · Mg0039 10103, Co… | 2026-09-16 → 2031-01-23 | Ouvrir |
| NCT07463521 MyVision — A Study to Evaluate the Efficacy and Safety of Rozanolixizum… |
rozanolixizumab | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | UCB Biopharma SRL | United States, Canada, China, Japan, Spain · Mg0038 1… | 2026-05-27 → 2029-01-22 | Ouvrir |
| NCT07673744 A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab … |
Ublituximab | Myasthénie | Phase 2 | RECRUITING | En attente / non publié | TG Therapeutics, Inc. | United States · TG Therapeutics Investigational Trial… | 2026-10-01 → 2030-01-01 | Ouvrir |
| NCT06867107 An Open-label Long-term Follow-up Study of SAT-3247 for Participants Wi… |
SAT-3247 | Myopathies | Phase 2 | ENROLLING_BY_INVITATION | En attente / non publié | Satellos Bioscience, Inc. | United States, Australia · Nationwide Children's Hosp… | 2025-08-20 → 2027-09-30 | Ouvrir |
| NCT04428476 HOPE-2-OLE — Open-label Extension of the HOPE-2 Trial |
Deramiocel (CAP-1002) | Myopathies | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Capricor Inc. | United States · Children's Hospital Colorado, Aurora,… | 2020-08-05 → 2027-03 | Ouvrir |
| NCT05481879 ACHIEVE — Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmaco… |
DYNE-101 | Myopathies | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Dyne Therapeutics | United States, Australia, France, Germany, Italy, Net… | 2022-09-05 → 2029-07 | Ouvrir |
| NCT05291091 Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON) |
Sevasemten 10 mg | Myopathies | Phase 2 | COMPLETED | En attente / non publié | Edgewise Therapeutics, Inc. | United States, Australia, Belgium, Denmark, France, G… | 2022-11-10 → 2026-09-07 | Ouvrir |
| NCT05548556 MANOEUVRE — A Study to Evaluate RO7204239 in Participants With Faciosca… |
RO7204239 | Myopathies | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Denmark, Italy, United Kingdom · Asst … | 2023-02-07 → 2026-10-09 | Ouvrir |
| NCT06455449 JASMINE — A Study to Investigate the Efficacy and Safety of Anifrolumab… |
Anifrolumab (blinded) | Myopathies | Phase 3 | RECRUITING | En attente / non publié | AstraZeneca | United States, Argentina, Australia, Austria, Belgium… | 2024-06-20 → 2029-04-09 | Ouvrir |
| NCT07839533 Acupuncture as an Adjunct Treatment for Lateral Epicondylitis |
Acupuncture | Myopathies | Non applicable | COMPLETED | En attente / non publié | The Hong Kong Polytechnic Univers… | Turkey (Türkiye) · Traditional and Complementary Medi… | 2025-04-05 → 2025-09-12 | Ouvrir |
| NCT06523400 The Efficacy and Safety of Once Daily Mexiletine PR in Patients With My… |
Mexiletine granules for prolonged… | Myopathies | Phase 3 | RECRUITING | En attente / non publié | Lupin Ltd. | Belgium, Denmark, Germany, Italy, Spain, United Kingd… | 2025-02-13 → 2027-06 | Ouvrir |
| NCT07838584 Comparison of Ischemic Release and Sustained Pressure Direct Myofascial… |
Ischemic release | Myopathies | Non applicable | RECRUITING | En attente / non publié | Foundation University Islamabad | Pakistan · Foundation University College of Physical … | 2026-09-09 → 2027-01-18 | Ouvrir |
| NCT07321158 PD-NMES-SPAS — The Effectiveness of Different Pulse Duration of NMES in… |
High Pulse Duration Neuromuscular… | Myopathies | Non applicable | COMPLETED | En attente / non publié | University of West Attica | Greece · Attikon Hospital, Athens, Greece | 2026-01-06 → 2026-07-31 | Ouvrir |
| NCT03521076 Randomized Controlled Trial of Virtual Reality |
Virtual Reality | Myopathies | Non applicable | COMPLETED | En attente / non publié | Gillette Children's Specialty Hea… | United States · GilletteChildren's Specialty Healthca… | 2018-09-21 → 2023-05-17 | Ouvrir |